Preclinical CRO Market Size is expected to reach USD 11.8 billion by 2034
The preclinical CRO market was valued at USD 2.42 billion in 2024 and is expected to reach USD 11.8 billion by 2034, with a compound annual growth rate (CAGR) of 9.6% during the 2025–2035 forecast period. The market is expected to grow due to the growing emphasis on outsourcing by biotechnology and pharmaceutical companies to cut costs and speed up drug discovery processes, as well as the demand for specialized preclinical services, particularly in areas like genomics, toxicology, and bioinformatics. Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/preclinical-cro-market GROWTH DRIVERS A major factor driving the growing trend of pharmaceutical and biotechnology companies outsourcing preclinical research activities to CROs is the cost reduction in the ongoing rise in global R&D expenditures as companies increase their R&D investments and seek out external partners with the infrastructure and expertise to carry out pre...